Getting ready for an FDA inspection

FDA describes its Investigations Operations Manual as the primary operational reference for investigators and other field employees. It is publicly available to help regulated industry understand FDA operations, and it includes a chapter devoted to inspections. The landing page identifies the reference and its structure; it does not give a prediction of the route an investigator will take through a particular plant.

A site can use that distinction when preparing. Learn the regulatory setting and the purpose of inspection activity, then examine the actual manufacturing system. Avoid assuming that a remembered sequence of questions will match the next inspection. Records retrieval, clear explanations and accurate identification of responsibilities are useful across many lines of inquiry.

An operator can prepare by reviewing the procedure used at the workstation and the records completed during the task. A supervisor can check how work moves between shifts and how an unusual condition reaches quality staff. A laboratory technician can trace a result back to the sample and original data. These are different responsibilities, so preparation should reflect the work each role performs.

A practice discussion can reveal unclear handoffs. Ask someone to explain a task using the approved procedure, then locate the evidence of a recent execution. If the explanation depends on an unwritten exception, that is a system issue to examine. The aim is accurate understanding. Memorising a reassuring answer leaves the underlying weakness in place and can make follow-up questions harder to answer.

Useful records preparation follows a manufacturing event from beginning to end. Identify the approved instructions, material status, equipment status, execution record, laboratory results, deviations and release decision. A missing link becomes visible when these items are reviewed together. Checking a stack of completed forms in isolation may overlook contradictions between them.

Teams commonly keep a retrieval process with clear ownership. Someone knows where controlled records are held, who can access them and how to provide the requested version. Electronic records need the same attention as paper records. A readable output should remain connected to its supporting data, and an unexplained revision deserves investigation through the company’s approved process.

A floor review can test whether written controls are visible in daily practice. Consider a drum with uncertain status, an equipment tag that conflicts with the log, or a cleaning entry that does not identify the equipment involved. These examples are prompts for an internal review, not a prediction of specific inspection findings. Each raises the same question: what prevents an incorrect action at the point of use?

Follow the movement of materials and information between areas. A process may appear clear within a room yet become ambiguous at the doorway or shift handoff. Review how people distinguish released, held and rejected material, how changes reach the workstation, and how exceptions are escalated. The internal auditing page explains how these checks can become a structured review.

During an inspection, a useful explanation answers the question asked and identifies the supporting record. When an answer is uncertain, the uncertainty should remain visible while the appropriate person or document is located. Guessing can create a conflict that later requires additional explanation. The person who performs a task may describe it more accurately than someone who only knows the department summary.

A site often coordinates record requests so that the scope of each request and the response can be followed. That coordination should support access to accurate information. It should also help the team notice a misunderstanding early. If a record appears inconsistent, address the inconsistency through the approved quality process and retain the evidence rather than replacing it with a cleaner-looking account.

FDA’s Form 483 questions and answers explain that the form is issued at the conclusion of an inspection when investigators observe conditions that, in their judgment, may constitute violations. The observations are discussed with management. FDA also makes clear that a Form 483 is not a final agency determination of a violation and is not an exhaustive list of every possible problem.

The background account of Form FDA 483 likewise describes it as a means of documenting and communicating inspection concerns. At close-out, understanding each observation matters. Distinguish the condition observed, the evidence behind it and any explanation the site provided. Agreement about wording is different from evidence that the underlying condition has been corrected.

FDA encourages companies to respond to a Form 483 in writing with a corrective action plan and to implement that plan promptly. Its explanation also says that related conditions may exist beyond those cited. A practical response process therefore examines scope as well as the immediate example. Correcting a single missing entry may leave the record process that allowed it unchanged.

Keep the investigation, proposed action, completed action and effectiveness evidence distinguishable. An action can be completed without demonstrating that the problem will not recur. A procedure revision needs an implementation check; a changed control needs evidence from actual work. The page on observations and warning letters develops this response approach. Inspection readiness becomes more durable when these lessons change ordinary operations and remain visible in the next review.